Arrowhead Pharmaceuticals to Join S&P MidCap 400: What the Index Shift Means for ARWR
Market Chameleon (Thu, 5-Feb 8:40 AM)
Arrowhead Pharmaceuticals Raises $625M in Convertible Notes and Upsizes Offerings: What Does This Mean for Investors?
Market Chameleon (Thu, 8-Jan 9:33 AM)
Arrowhead’s REDEMPLO Wins Health Canada Approval—A Potential Breakthrough for Rare Lipid Disorder Patients
Market Chameleon (Tue, 6-Jan 11:07 AM)
ARWR Trial Data Shows ARO-INHBE Combination Doubles Weight Loss and Triples Fat Reduction in Obese Diabetics
Market Chameleon (Tue, 6-Jan 7:51 AM)
